Clinical Trial Update: Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing micafungin to conventional amphotericin B for neonatal candidiasis was terminated, with results posted in 2015. The update suggests th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Neonatal Candidiasis

Drugs mentioned

• Amphotericin B (Amphotericin B)
• Micafungin (micafungin)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Candidiasis | Phase 3 | Status: TERMINATED | Results posted: 2015-09-15